p27Kip1: Chromosomal Mapping to 12p12–12p13.1 and Absence of Mutations in Human Tumors

Cancer Research

Volumn 55, Issue 6, 1995, Pages 1211-1214

  Ponce Castañeda, M Veronica ^a   Lee, Mong Hong ^a,b   Latres, Esther ^a   Polyak, Kornelia ^a   Lacombe, Louis ^a   Mathew, Susan ^a   Sheinfeld, Joel ^a   Massague, Joan ^a,b   Cordon Cardo, Carlos ^a   Montgomery, Kate ^c   Krauter, Kenneth ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIP1 PROTEIN; CYCLINE; PROTEIN KINASE; CYCLIC AMP; CYCLIN DEPENDENT KINASE; DNA; ENZYME INHIBITOR; RAPAMYCIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CHROMOSOME 12; CHROMOSOME MAP; GENETICS; HUMAN; MOLECULAR GENETICS; MUTATION; NEOPLASM; NUCLEOTIDE SEQUENCE; AGAR GEL ELECTROPHORESIS; CANCER CELL; CELL PROLIFERATION; CHROMOSOME 12P; CONTROLLED STUDY; DNA SEQUENCE; FLUORESCENCE; HUMAN TISSUE; HYBRID CELL; IN SITU HYBRIDIZATION; LEUKEMIA; MESOTHELIOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 12; CYCLINS; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; PROTEIN KINASES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028986932     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Hartwell, L. H. Defects in a cell cycle checkpoint may be responsible for genomic instability of cancer cells. Cell, 71: 543–546, 1992.
2. Nurse, P. Universal control mechanism in regulating onset of M-phase. Nature (Lond.), 344: 503–508, 1990.
3. Reed, S. I. The role of p34 kinases in the Gl to S-phase transition. Annu. Rev. Cell Biol., 8: 529–561, 1992.
4. Lammie, G. A., and Peters, G. Chromosome llql3 abnormalities in human cancer. Cancer Cells (Cold Spring Harbor), 3: 413–420, 1991.
5. Gillett, C., Ranti, V., Smith, R., Fisher, G., Bartek, J., Dickson, G., Barnes, D., and Peters, G. Amplification and overexpression of cyclin Dl in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812–1817, 1994.
6. Khatib, Z. A., Matsushime, H., Valentine, M., Shapiro, D. N., Sherr, G J., and Look, A. T. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res., 53: 5535–5541, 1993.
7. Peter, M., and Herskowitz, I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell, 79: 181–184, 1994.
8. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701–704, 1993.
9. Harper, J. W., Adami, G. W., Wei, N., Keyomarsi, J., and Elledge, S. J. The p21 cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell, 75: 805–816, 1993.
10. Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., and Smith, J. R. Coning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211: 90–98, 1994.
11. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinder, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817–825, 1993.
12. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p55-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced Gl arrest. Cell, 76: 1013–1023, 1994.
13. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704–707, 1993.
14. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436–440, 1994.
15. Norobi, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancer. Nature (Lond.), 368: 753–756, 1994.
16. Hannon, G. J., and Beach, D. pl5INK4B is a potential effector of TGF-0-induced cell cycle arrest. Nature (Lond.), 371: 257–261, 1993.
17. Weaver-Feldhaus, J., Gruis, N. A., Neuhausen, S., Paslier, D. L., Stockert, E., Skolnick, M. H., and Kamb, A. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc. Natl. Acad. Sci. USA, 91: 7563–7567, 1994.
18. Orlow, I., Lianes, P., Lacombe, L., Dalbagni, G., Reuter, V. E., and Cordon-Cardo, C. Chromosome 9 deletions and microsatellite alterations in human bladder tumors. Cancer Res., 54: 2848–2851, 1994.
19. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK41k (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54: 3396–3397, 1994.
20. Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Jr., Tucer, M. A., and Dracopoli, N. C. Germline p16 mutations in familial melanoma. Nat. Genet., 8: 15–21, 1994.
21. Polyak, K., Kato, J.-Y., Solomon, M. J. Sherr, C. J. Massague, J., Roberts, J. M., and Koff, A. p27Kipl, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev., 8: 9–22, 1994.
22. Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., and Massague, J. Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78: 59–66, 1994.
23. Toyoshima, H., and Hunter, T. p27, a novel inhibitor of Gl cyclin-cdk protein kinase activity, is related to p21. Cell, 78: 61–14, 1994.
24. Kato, J., Matsuoka, M., Polyak, K., Massague, J., and Sherr, C. J. Cyclic AMP-induced Gl phase arrest mediated by an inhibitor (p27Kipl) of cyclin-dependent kinase 4 activation. Cell, 79: 487–496, 1994.
25. Nourse, J., Firpo, E., Flanagan, W. M., Meyerson, M., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., and Roberts, J. M. Rapamycin prevents IL-2-mediated elimination of the cyclin-CDK kinase inhibitor, p27Kipl. Nature (Lond.), 372: 570–573, 1994.
26. Fynan, T. M., and Reiss, M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncol., 4: 493–540, 1993.
27. Cordon-Cardo, C., Latres, E., Drobnjak, M., Oliva, M. R., Pollack, D., Woodruff, J. M., Marechal, V., Chen, J., Brennan, M. F., and Levine, A. J. Molecular abnormalities of MDM-2 and P53 genes in adult soft tissue sarcomas. Cancer Res., 54: 794–799, 1994.
28. Cordon-Cardo, C., Dalbagni, D, Saez, G. T., Oliva, M. R., Zhang, Z.-F., Rosai, J.,Reuter, V. E., and Pellicer, A. TP53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int. J. Cancer, 56: 347–353, 1994.
29. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874–879, 1989.
30. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463–5467, 1977.
31. Matthew, S., Murty, V. V. V. S., Hunziker, W., and Chaganti, R. S. K. Subregional mapping of 13 single-copy genes on the long arm of chromosome 12 by fluorescence in situ hybridization. Genomics, 14: 775–779, 1992.
32. Chan, L. C., Kwong, Y. L., Iiu, H. W., Lee, C. P., Lie, K. W., and Chan, A. Y. Deletion 12p in de novo acute myeloid leukemia. An association with early progenitor cell. Cancer Genet. Cytogenet., 62: 41–49, 1992.
33. Decker, H. J., Li, F. P., Bixenman, H. A., and Sandberg, A. A. Chromosome 3 and 12p rearranged in a well-differentiated peritoneal mesothelioma. Cancer Genet. Cytogenet., 46: 135–137, 1990.
34. Rodriguez, E., Mathew, S., Reuter, V., Ilson, D. H., Bosl, G. J., and Chaganti, R. S. K. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res., 52: 2285–2291, 1992.
35. Spelman, F., Laureys, G., Benoit, Y., Cuvelier, C., Suijkerbuijk, R., and De Jong, B. i(12p) in a near-diploid mature ovarian teratoma. Cancer Genet. Cytogenet, 60: 216–218, 1992.
36. Spelman, F., DePotter, C., Dal Cin, P., Mangelschots, K., Ingelaere, H., Laureys, G., Benoit, Y., Leroy, J., and Van Den Berghe, H. i(12p) in a malignant ovarian tumor. Cancer Genet. Cytogenet., 45: 49–53, 1990.
37. Berube, N. G., Speevak, M. D., and Chevrette, M. Suppression of tumorigenicity of human prostate cancer cells by introduction of human chromosome del(12Xql3). Cancer Res., 54: 3077–3081, 1994.
38. Pietenpol, J. A., Bohlander, S. K., Sato, Y., Papadopoulous, N., Liu, B., Friedman, G., Trask, B. J., Roberts, J. M., Kinzler, K. W., Rowley, J. D., and Vogelstein, B. Assignment of the human p27Kipl gene to 12pl3 and its analysis in leukemias. Cancer Res., 55: 1206–1210, 1995.
39. Bullrich, F., MacLachlan, T. K., Sang N., Druck, T., Veronese, M. L., Allen, S. L., Chiorazzi, N., Koff, A., Huebner, K., Croce, C. M., and Giordano, A. Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, P1SSLRE, and PTTALRE, and a cdk inhibitor, p27Kipl, to regions involved in human cancer. Cancer Res., 55: 1199–1205, 1995.